DIN 02241835 · ended Sep 9, 2022 · Delay in shipping of the drug.
Showing 12 of 19 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Estradiol Norethindrone. Health Canada has 19 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Estradiol Norethindrone is classified under “PROGESTOGENS AND ESTROGENS IN COMBINATION” (ATC G03FA).
Recent changes
Sep 2, 2026
Shortage resolved
Aug 24, 2026
Status changed
Aug 24, 2026
Estimated end date pushed back : Aug 21, 2026 → Aug 28, 2026
Aug 10, 2026
Estimated end date moved earlier : Aug 31, 2026 → Aug 21, 2026
Jul 16, 2026
New report filed
Common questions
What is Estradiol Norethindrone used for?
A combined hormone therapy used to relieve menopausal symptoms.
When will Estradiol Norethindrone be back in stock in Canada?
Estradiol Norethindrone has no active shortage; supply is normal per Health Canada reports.
Why is Estradiol Norethindrone in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.